The first chlamydia vaccine to reach Phase I clinical trials has been observed to be safe and immunogenic in 35 women.
Browsing: Clinical > Vaccines
In a study of healthy infants, researchers discover exposure to C. difficile in infancy may provide natural immunization later in childhood.
Researchers from the University of Texas at Austin have passed an experimental RSV vaccine through Phase I human clinical trial with promising results.
Take a look at this month’s industry headlines including a US FDA approval for RECARBRIO™, positive results for XOFLUZA in children and new ACIP recommendations.
A DNA vaccine for MERS-CoV was demonstrated to be well-tolerated and immunogenic in a Phase I, first-in-human trial.
New research has revealed a dangerous stagnation in the global vaccination rates of children, owing to inequality, conflict and complacency.
Take a look at this month’s industry headlines including an FDA approval for Zebraxa, new funding for chikungunya vaccine clinical…
A new meta-analysis including data from 60 million individuals over 8 years has demonstrated significant decreases in HPV infections, anogenital wart diagnoses and precancerous cervical lesions following HPV vaccination in girls.
New study determines a neutralizing antibody which binds to the most pandemic strain of norovirus in humans that could be utilized for an effective vaccine.
A study has revealed genetic variants associated with differing levels of protective antibodies produced after routine immunizations.